Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-31
1997-08-12
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, C07K 1400
Patent
active
056565992
ABSTRACT:
This invention relates to E2 trans-activation repressors which interfere with normal functioning of the native full-length E2 transcriptional activation protein of the papillomavirus. Native full-length E2 trans-activation protein activates transcription of papillomavirus only through binding to DNA, and it binds to DNA only in the form of a pre-formed homodimer--a pair of identical polypeptide subunits held together by non-covalent interactions. The E2 trans-activation repressors of this invention are proteins, polypeptides or other molecules that dimerize with full-length native E2 polypeptides to form inactive heterodimers, thus interfering with the formation of active homodimers comprising full-length native E2 polypeptides, thereby repressing papillomavirus transcription and replication. The E2 trans-activation repressors of this invention are advantageously used in the treatment of papillomavirus infections and their associated diseases.
REFERENCES:
patent: 4777239 (1988-10-01), Schoolnik et al.
patent: 5219990 (1993-06-01), Androphy
Selden, R.F., "Assay for Human Growth Hormone," in Current Protocols in Molecular Biology, pp. 9.7.1-9.7.3 (1990, F.M. Ausubel et al., eds.).
Shen, W.C. et al., "Conjugation of poly-L-lysine to Albumin and Horseradish Peroxides: A Novel Method of Enhancing the Cellular Uptake of Proteins", Proc. Natl. Acad. Sci. USA, 75, pp. 1872-1876 (1978).
Sousa, R. et al., "Control of Papillomavirus Gene Expression", Biochim. Biophys. Acta., 1032, pp. 19-37 (1990).
Spalholz, B.A. et al., "Transactivation of a Bovine Papilloma Virus Transcriptional Regulatory Element by the E2 Gene Product", Cell, 42, pp. 183-191 (1985).
Spalholz, B.A. et al., "Bovine Papillomavirus Transcriptional Regulation: Localization of the E2-Responsive Elements of the Long Control Region", J. Virol., 61, pp. 2128-2137 (1987).
Stenlund, A. et al. "The E2 trans-Activator Can Act as a Repressor by Interfering with a Cellular Transcription Factor", Genes Dev., 4, pp. 123-136 (1990).
Studier, F.W. et al., "Use of T7 RNA Polymerase to Direct Expression of Cloned Genes", Meth. Enzymol., 185, pp. 60-89 (1990).
Aaronson, S.A. et al., "Development of 3T3-like Lines from Balb/c Mouse Embryo Cultures: Transformation Susceptibility to SV40", J. Cell Physiol., 72, pp. 141-148 (1968).
Androphy, E.J. et al., "Bovine Papilomavirus E2-Trans-Activating Gene Product Binds to Specific Sites in Papillomavirus DNA", Nature, 325, pp. 70-73 (1987).
Barsoum, J., "Introduction of Stable High-Copy-Number DNA into Chinese Hamster Ovary Cells by Electroporation", DNA Cell Biol., 9, pp. 293-300 (1990).
Barsoum, J. et al., "Mechanism of Action of the Papillomavirus E2 Repressor: Repression in the Absence of DNA Binding", J. Virol., 66, pp. 3941-3945 (1992).
Cate, R.L. et al., "Isolation of the Bovine and Human Genes for Mullerian Inhibiting Substance and Expression of the Human Gene in Animal Cells", Cell, 45, pp. 685-698 (1986).
Chen, E.Y. et al., "The Primary Structure and Genetic Organization of the Bovine Papillomavirus Type 1 Genome", Nature, 299, pp. 529-534 (1982).
Chodosh, L.A., "MobilityShift DNA-Binding Assay Using Gel Electrophoresis" in Current Protocols in Molecular Biology, pp. 12.2.1-12.2.10 (1990, F.M. Ausubel et al., eds.).
Choe, J. et al., "Bovine Papillomavirus Type 1 Encodes Two Forms of a Transcriptional Repressor: Structural and Functional Analysis of New Viral cDNAs", J. Virol., 63, pp. 1743-1755 (1989).
Chu, G. et al., "Electroporation for the Efficient Transfection of Mammalian Cells with DNA", Nuc. Acids Res., 15, pp. 1311-1326 (1987).
Dartmann, K. et al., "The Nucleotide Sequence and Genome Organization of Human Papilloma Virus Type 11", Virology, 151, pp. 124-130 (1986).
De Villiers, E.M., "Heterogeneity of the Human Papillomavirus Group", J. Virol., 63, pp. 4898-4903 (1989).
Dostatni, N., et al., "A Dimer of BPV-1 E2 Containing A Protease Resistant Core Interacts with its DNA Target", EMBO J., 7, pp. 3807-3816 (1988).
Giri, I. et al., "Structural and Mutational Analysis of E2 Trans-Activating Proteins of Papillomaviruses Reveals Three Distinct Functional Domains", EMBO J., 7, pp. 2823-2829 (1988a).
Giri, I. et al., "Study of the E2 Gene Product of the Cottontail Rabbit Papillomavirus Reveals a Common Mechanism of Transactivation Among Papillomaviruses", J. Virol., 62, pp. 1573-1581 (1988b).
Gorman, C.M. et al., "Recombinant Genomes which Express Chloramphenicol Acetyltransferase in Mammalian Cells", Mol. Cell. Biol., 2, pp. 1044-1051 (1982).
Haugen, T.H. et al., "Sequence-Specific and General Transcriptional Activation by the Bovine Papillomavirus-1 E2 trans-Activator Require an N-Terminal Amphipathic Helix-Containing E2 Domain", EMBO J., 7, pp. 4245-4253 (1988).
Haugen, T.H. et al., "Trans-Activation of an Upstream Early Gene Promoter of Bovine Papillomavirus-1 by a Product of the Viral E2 Gene", EMBO J., 6, pp. 145-42 (1987).
Hawley-Nelson, P. et al., "The Specific DNA Recognition Sequence of the Bovine Papillomavirus E2 Protein is an E2-Dependent Enhancer", EMBO J., 7, pp. 525-531 (1988).
Hirochika, H. et al., "Enhancers and trans-Acting E2 Transcriptional Factors of Papillomaviruses", J. Virol., 61, pp. 2599-2606 (1987).
Hirochika, H. et al., "Functional Mapping of the Human Papillomavirus Type 11 Transcriptional Enhancer and its Interaction with the trans-Acting E2 Proteins", Genes Dev., 2, 54-67 (1988).
Hoffmann, P., et al., "Stimulation of Human and Murine Adherent Cells by Bacterial Lipoprotein and Synthetic Lipopeptide Analogues", Immunobiology, 177, pp. 158-170 (1988).
Kost, T.A. et al., "The Nucleotide Sequence of the Chick Cytoplasmic .beta.-Actin Gene", Nuc. Acids Res., 11, pp. 8287-8301 (1983).
Kunkel, T.A. et al., "Rapid and Efficient Site-Specific Mutagenesis Without Phenotypic Selection", Meth. Enzymol., 154, pp. 367-382 (1987).
Lambert, P.F. et al., "Functional Analysis Of The Papilloma Virus E2 Trans-Activator In Saccharomyces Cerevisiae", Genes & Devel., 3, pp. 38-48 (1989).
Lambert, P.F. et al., "Phenotypic Analysis of Bovine Papillomavirus Type 1 E2 Repressor Mutants", J. Virol. 64, pp. 950-956 (1990).
Lambert, P.F. et al., "A Transcriptional Repressor Encoded by BPV-1 Shares a Common Carboxy-Terminal Domain with the E2 Transactivator", Cell, 50, pp. 69-78 (1987).
Lambert, P.F. et al., "Genetic Assignment of Multiple E2 Gene Products in Bovine Papillomavirus-Transformed Cells", J. Virol., 63, pp. 3151-3154 (1989).
Li, R. et al., "Specific Recognition Nucleotides and Their DNA Context Determine the Affinity of E2 Protein for 17 Binding Sites in the BPV-1 Genome", Genes Dev., pp. 510-526 (1989).
McBride A.A. and P.M. Howley, "Characterization of the DNA Binding/Dimerization Domain Shared By The E2 Regulatory Proteins Of BPV-1" J. Cell. Biochem., Supp.13C:191 (Abstract #I 135) (1989a).
McBride, A.A. et al., "E2 Polypeptides Encoded by Bovine Papillomavirus Type 1 Form Dimers through the Common Carboxyl-Terminal Domain: Transactivation is Mediated by the Conserved Amino-Terminal Domain", Proc. Natl. Acad. Sci. USA, 86, pp. 510-514 (1989b).
McBride, A.A. et al., "Phosphorylation Sites of the E2 Transcriptional Regulatory Proteins of Bovine Papillomavirus Type 1", J. Virol. 63, pp. 5076-5085 (1989c).
McBride, A.A. et al., "Bovine Papillomavirus With A Mutation In The E2 Serine 301 Phosphorylation Site Replicates At A High Copy Number", J. Virol., 65, pp. 528-534 (1991).
McBride, A.A. et al., "The Carboxy-Terminal Domain Shared by the Bovine Papillomavirus E2 Transactivator and Repressor Proteins Contains a Specific DNA Binding Activity", EMBO J., 7, pp. 533-539 (1988).
McKay, R.D.G., "Binding of a Simian Virus 40 T Antigen-Related Protein to DNA", J. Mol. Biol., 145, pp. 471-488 (1981).
Merrifield R.B., "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide", J. Am. Chem. Soc., 85, pp. 2149-2154 (1963).
Mohr, I.J. et al., "Targeting the E1 Replication Protein to the Papillomavirus Origin of Replication Protein to the Papillomavirus Origin of Replication by Complex Formation with the E2 Transactivator", Science, 250, pp. 1694-1699 (1990).
Morrissey, L.C. e
Androphy Elliot J.
Barsoum James G.
Biogen Inc.
Carlson K. Cochrane
Haley, Jr. James F.
Kanter Madge R.
New England Medical Center Hospitals Inc.
LandOfFree
Papillomavirus E2 trans-activation repressors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Papillomavirus E2 trans-activation repressors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Papillomavirus E2 trans-activation repressors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-160518